UnitedHealth Group (NYSE:UNH) Issues Earnings Results, Beats Expectations By $1.51 EPS

UnitedHealth Group (NYSE:UNH) announced its earnings results on Thursday. The healthcare conglomerate reported $6.38 EPS for the quarter, topping analysts’ consensus estimates of $4.87 by $1.51, FiscalAI reports. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The business had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. During the same period in the previous year, the company posted $4.08 earnings per share. The firm’s revenue was up .4% on a year-over-year basis. UnitedHealth Group updated its FY 2026 guidance to 19.500-20.000 EPS.

Here are the key takeaways from UnitedHealth Group’s conference call:

• UnitedHealth raised its full-year 2026 outlook, now guiding to adjusted EPS of $19.50 to $20.00 and higher operating earnings for both UnitedHealthcare and Optum Health after a stronger-than-expected second quarter.
• Commercial medical cost trends remain elevated, with management saying they are running modestly above 11% and that margin recovery in the commercial business will take longer than previously expected.
• Medicare Advantage performance improved, with lower-than-expected medical trend versus its original 2026 assumptions and better membership retention; the company now expects Medicare margins above 3% for the year.
• Medicaid remains pressured as reimbursement rates continue to lag medical cost trends, even though second-quarter results were in line with expectations and management sees only early signs of improvement.
• Optum businesses showed momentum, especially Optum Health, where care management, patient access, and AI-enabled workflow tools are improving experience and operations, while Optum Rx and Optum Insight continue to gain traction with transparency and AI-driven offerings.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $423.27 on Friday. The business’s fifty day simple moving average is $403.87 and its 200-day simple moving average is $341.69. UnitedHealth Group has a 52 week low of $234.60 and a 52 week high of $461.62. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. The firm has a market cap of $384.39 billion, a PE ratio of 31.97, a price-to-earnings-growth ratio of 1.68 and a beta of 0.62.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were issued a $2.32 dividend. This represents a $9.28 annualized dividend and a yield of 2.2%. The ex-dividend date was Monday, June 15th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s dividend payout ratio (DPR) is currently 70.09%.

Analyst Ratings Changes

Several analysts have weighed in on the stock. Morgan Stanley upped their price target on shares of UnitedHealth Group from $453.00 to $468.00 and gave the company an “overweight” rating in a research note on Tuesday, June 30th. Zacks Research upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Monday. Cantor Fitzgerald reiterated an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, June 11th. Royal Bank Of Canada raised their price objective on UnitedHealth Group from $400.00 to $463.00 and gave the stock an “outperform” rating in a research note on Thursday, July 9th. Finally, Raymond James Financial raised shares of UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price target for the company in a research report on Wednesday, April 1st. Two analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $438.92.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth’s Q2 results beat expectations on both earnings and revenue, driven by better cost control and stronger performance at Optum. UnitedHealth Group Reports Second Quarter 2026 Results
• Positive Sentiment: The company raised its 2026 profit guidance and said it is on track for at least $5 billion in share repurchases this year, signaling confidence in cash generation. UnitedHealth raises 2026 forecast as it controls medical costs
• Positive Sentiment: Management said the turnaround is gaining momentum, which boosted optimism that earnings recovery could continue into the second half of the year. UnitedHealth blows past estimates, hikes earnings outlook as it reins in costs
• Neutral Sentiment: Robert W. Baird raised UNH to Neutral and increased its price target, reflecting a more balanced view after the rally. UnitedHealth Group (NYSE:UNH) Rating Increased to Neutral at Robert W. Baird
• Negative Sentiment: Some commentary cautioned that elevated medical-cost pressures still remain a risk for managed-care peers and for UNH’s margin outlook. Why Elevance Earnings Gave Health Insurance Stocks A Cold; UNH Up Next

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction dated Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the transaction, the chief executive officer owned 17,805 shares in the company, valued at approximately $6,320,775. This represents a 4.30% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.28% of the company’s stock.

Institutional Investors Weigh In On UnitedHealth Group

A number of institutional investors have recently added to or reduced their stakes in UNH. Sunbelt Securities Inc. raised its position in UnitedHealth Group by 4.9% in the fourth quarter. Sunbelt Securities Inc. now owns 1,416 shares of the healthcare conglomerate’s stock worth $467,000 after acquiring an additional 66 shares in the last quarter. Mcguire Capital Advisors Inc. purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $40,000. Compound Planning Inc. boosted its holdings in UnitedHealth Group by 10.5% during the fourth quarter. Compound Planning Inc. now owns 9,744 shares of the healthcare conglomerate’s stock worth $3,217,000 after buying an additional 927 shares in the last quarter. Axxcess Wealth Management LLC lifted its position in shares of UnitedHealth Group by 3.3% during the 4th quarter. Axxcess Wealth Management LLC now owns 18,902 shares of the healthcare conglomerate’s stock valued at $6,240,000 after acquiring an additional 611 shares during the period. Finally, Corient Private Wealth LLC grew its holdings in shares of UnitedHealth Group by 4.8% in the 4th quarter. Corient Private Wealth LLC now owns 431,657 shares of the healthcare conglomerate’s stock worth $142,494,000 after acquiring an additional 19,606 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.